Mutations responsible for attenuation in measles virus or...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 7/04 (2006.01) A61K 39/165 (2006.01) C07K 14/12 (2006.01) C07K 14/135 (2006.01)

Patent

CA 2323927

Isolated, recombinantly-generated, attenuated measles viruses and respiratory syncytial subgroup B viruses having defined attenuating mutations are described. Vaccines are formulated comprising such viruses and a physiologically acceptable carrier. The vaccines are used for immunizing an individual to induce protection against measles virus or respiratory syncytial subgroup B virus.

L'invention concerne le virus de la rougeole et le virus respiratoire syncytial humain du sous-groupe B, ces virus étant isolés, générés par recombinaison et atténués et présentant des mutations d'atténuation définies. L'invention concerne également des formulations de vaccins comprenant ces virus et un excipient physiologiquement acceptable. Les vaccins s'utilisent pour immuniser un individu et le protéger contre le virus de la rougeole ou le virus respiratoire syncytial humain du sous-groupe B.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutations responsible for attenuation in measles virus or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutations responsible for attenuation in measles virus or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutations responsible for attenuation in measles virus or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1360644

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.